Rocket Pharmaceuticals Inc (RCKT) Company Long-Term Loans and Borrowings

Brandmark of Rocket Pharma (RCKT)

Rocket Pharmaceuticals (RCKT) dominates the orphan disease therapy segment, offering unique stem cell correction methods with low demand elasticity. The company is creating a comprehensive environment for treating pediatric blood and heart defects, rendering its developments critical. The price history of the shares with the 0.02 indicator illustrates the asset's dynamics. Simultaneously, the enterprise is upgrading filtration systems and automating drug filling in its production facilities.

RCKT Rocket Pharmaceuticals, Inc.: Company Long-Term Debts in the range 07/04/2022 - 10/29/2026

Financial and market metric breakdowns for Rocket Pharmaceuticals Inc (RCKT)

- price and consensus price forecast:
Stock Price rocketpharma.com|RCKT - Price Target Chart
- market capitalization data:
Market Value Rocket Pharmaceuticals|RCKT - Total Company Value
- book capitalization data:
Net Asset Value per Share Rocket Pharmaceuticals|RCKT - Book Capitalization|Market Cap to Net Assets Ratio rocketpharma.com|RCKT - Aggregate Company Assets
- debt and liquidity data:
Total Debt to Capital Rocket Pharmaceuticals|RCKT - Long-Term Debt to Capital|Current Liabilities to Capital Rocket Corp|RCKT - Company Total Debt|Debt to Book Capital Rocket Pharmaceuticals|RCKT - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Rocket Pharmaceuticals
Fundamental company analysis:RCKT - rocketpharma.com
Original product of Rocket Pharmaceuticals, Inc.

Long-term liabilities determine the issuer's creditworthiness and its ability to fund strategic development through debt capital. This metric aggregates all long-term loans, allowing the trend of the business's long-term debt capital to track deleveraging dynamics in real time. For Rocket Pharmaceuticals (RCKT), this metric is critical, as the company accumulates resources for costly clinical trials. The increase in borrowings is justified until regulatory approvals are obtained and a premium payment model for therapy is launched.

Analysis of competing companies

Tempus Labs - Company Long-Term Debts|Company Long-Term Debt Qiagen (QGEN)|IONS: Company Long-Term Loans and Borrowings|Company Long-Term Debt RGEN|Avidity Corp (RNA) - Long-Term Debt|Company Long-Term Debts CRSP|Company Long-Term Liabilities WGS|Company Long-Term Debt RARE|Company Long-Term Debts Beam Therapeutics Inc (BEAM)|SRPT: Company Long-Term Debts|TWST - Long-Term Debt|Company Long-Term Liabilities 10x Genomics, Inc. TXG|intelliatx.com (NTLA) - Amount of Long-Term Liabilities|Company Long-Term Liabilities Stoke Therapeutics, Inc. STOK|BLFS (BioLife Solutions Inc) - Company Long-Term Loans and Borrowings|Company Long-Term Debt Wave Life Sciences Corp WVE|Long-Term Liabilities Maze Therapeutics Corp|Sionna Therapeutics Inc (SION) - Company Long-Term Debts|Company Long-Term Loans and Borrowings primemedicine.com (PRME)|Company Long-Term Debts TSHA (Taysha Gene Therapies, Inc.)|uniQure NV - Company Long-Term Debts|Company Long-Term Debt MeiraGTx PLC (MGTX)|RGNX: Company Long-Term Loans and Borrowings|SLDB (Solid Biosciences Inc.) - Company Long-Term Debt|ocugen.com (OCGN) - Company Long-Term Liabilities|PACB (PacBio) - Company Long-Term Debts|Company Long-Term Debts Benitec Biopharma Inc|Company Long-Term Debts DSGN (Design Pharma)|Company Long-Term Liabilities 4D Molecular Corp (FDMT)|LXEO: Company Long-Term Debts|KRRO - Long-Term Debt|Editas Medicine - Company Long-Term Liabilities|Silence Therapeutics PLC (SLN) - Company Long-Term Debts|PRQR - Company Long-Term Liabilities|Codexis (CDXS) - Amount of Long-Term Liabilities|SGMO: Company Long-Term Debts|Long-Term Debt Volume Nautilus Biotechnology Inc|Company Long-Term Debts MGX (Metagenomi)|Company Long-Term Liabilities Precision BioSciences Inc. (DTIL)|Company Long-Term Debts GBIO (Generation Bio)|Boundless Bio Inc - Company Long-Term Debts|XCUR - Company Long-Term Debt|IMNN: Company Long-Term Debt|phiopharma.com - Company Long-Term Debt|MBIO (Mustang Bio) - Long-Term Debt Volume|RNAZ - Company Long-Term Debt|Company Long-Term Loans and Borrowings Bionano|Company Long-Term Debts APDN (Applied DNA Sciences)|Company Long-Term Liabilities BLUE (bluebirdbio.com)|Company Long-Term Debt IPA (ImmunoPrecise Antibodies Ltd.)|OMGA - Company Long-Term Debts|Company Long-Term Liabilities Singular Genomics Systems Inc OMIC|RGLS - Amount of Long-Term Liabilities|Company Long-Term Debts Syros Pharmaceuticals|TBIO (telesisbio.com) - Company Long-Term Indebtedness|Company Long-Term Debt TRACON Pharmaceuticals, Inc. (TCON)|Company Long-Term Indebtedness Unity Biotechnology Inc.